Crossref

1. Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-naïve chronic hepatitis B patients: a prospective and randomized controlled trial

- Jing-Mao Yang

- Li-Ping Chen

- Ya-Jie Wang

- Bei Lyu

- Hong Zhao

- Zhi-Yin Shang

- Jun Li

- Zhen-Yu Fan

- Sheng-Di Wu

- Xiao Ming

- Xian Li

- Shao-Ping Huang

- Ji-Lin Cheng

2. Natural killer cells in hepatitis B virus infection

- Shao-fei Wu

- Wen-jing Wang

- Yue-qiu Gao

3. Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker

- Takayo Ota

- Tomoya Fukui

- Yoshiro Nakahara

- Takayuki Takeda

- Junji Uchino

- Takako Mouri

- Keita Kudo

- Saki Nakajima

- Tomohiro Suzumura

- Masahiro Fukuoka